UAE Stomach Cancer Treatment Market to Grow at 17.29% CAGR through 2030
Rising cancer awareness and advancements in medical
technology is expected to drive the UAE Stomach Cancer Treatment Market growth
in the forecast period, 2026-2030.
According to TechSci Research report, “UAE Stomach
Cancer Treatment Market –By Region, Competition, Forecast and Opportunities, 2020-2030F”,
the UAE Stomach Cancer Treatment Market stood at USD 8.35 Million in 2024 and is expected
to reach USD 21.79 Million with a CAGR of 17.29% through 2030.
The UAE Stomach Cancer Treatment Market is witnessing
significant growth, driven by a combination of increasing awareness, advancements
in medical technology, rising healthcare investments, and the country’s growing
role as a hub for medical tourism. Stomach cancer, which includes gastric
cancer and cancers of the gastroesophageal junction, is becoming a major health
concern in the UAE due to factors such as lifestyle changes, dietary habits,
and an aging population. The demand for stomach cancer treatments in the UAE is
rising rapidly as early diagnosis and treatment options become more accessible.
One of the most prominent factors driving the growth
of the UAE Stomach Cancer Treatment Market is the increasing incidence of
stomach cancer in the country. As lifestyle-related diseases such as obesity,
smoking, and unhealthy eating habits continue to rise, the number of people
diagnosed with stomach cancer is increasing. The UAE's rapidly growing aging
population also plays a significant role in the higher prevalence of cancer
cases, particularly those affecting the digestive system. As a result, there is
an urgent need for innovative diagnostic tools and advanced treatment methods
to combat this issue.
The UAE government’s continuous efforts to improve
healthcare infrastructure have further fueled the growth of the stomach cancer
treatment market. The country has made significant investments in building
state-of-the-art medical facilities and expanding specialized cancer centers.
This has led to better access to healthcare services, including early
detection, treatment options, and specialized care for cancer patients. Several
hospitals in the UAE have adopted the latest technologies in diagnostic imaging,
treatment planning, and minimally invasive surgeries, which have contributed to
the increased efficacy and speed of stomach cancer treatments.
Medical tourism is also a major contributor to the
growth of the UAE Stomach Cancer Treatment Market. The country has become a top
destination for patients from neighboring regions such as the Middle East,
North Africa, and South Asia, who seek advanced treatment options for stomach
cancer. Dubai, in particular, has emerged as a healthcare hub, attracting
international patients due to its world-class medical facilities,
internationally trained healthcare professionals, and cutting-edge treatment
modalities. The availability of specialized cancer care centers, medical
technologies like robotic surgery, and comprehensive treatment options has made
the UAE an attractive location for people seeking the best medical care.
In addition to traditional treatments such as
chemotherapy and surgery, the UAE has seen a rise in targeted therapies and
immunotherapies for stomach cancer treatment. These newer therapies, which
focus on attacking cancer cells while sparing healthy tissues, are gaining
popularity due to their effectiveness and reduced side effects compared to
conventional treatments. The increasing availability and adoption of these
advanced therapies have expanded the scope of treatment options available to
patients, further boosting the market growth.
The increasing awareness of stomach cancer in the UAE
has played a critical role in early diagnosis and timely treatment. Public
awareness campaigns, government-led initiatives, and the increasing number of
screenings are encouraging more people to seek medical attention at the onset
of symptoms. This proactive approach to healthcare is driving demand for
diagnostic services such as endoscopies, imaging, and blood tests, which are
essential in detecting and staging stomach cancer early on. As awareness grows,
more people are visiting hospitals for consultations, leading to a rise in the
number of diagnoses and, subsequently, treatments.
Several challenges, however, continue to shape the UAE
Stomach Cancer Treatment Market. One of the main challenges is the high cost of
cancer treatment, which can be a significant burden for patients, especially in
the absence of adequate insurance coverage. The cost of advanced therapies,
surgical procedures, and hospitalization can limit access to treatment for some
individuals, making affordability an issue. The market is also facing
challenges in terms of awareness in certain segments of the population, where
late-stage diagnosis remains common due to lack of education about cancer
prevention and symptoms.
Another challenge is the shortage of specialized
oncologists and healthcare professionals in the country. While the UAE boasts
high-quality healthcare professionals, the demand for specialized cancer care
outpaces the supply, leading to longer wait times for appointments and
treatment. The complexity of stomach cancer diagnosis and treatment requires a
multidisciplinary approach, involving surgeons, oncologists, pathologists, and
radiologists, which can sometimes strain healthcare resources. Despite these challenges,
the UAE Stomach Cancer Treatment Market is expected to continue growing, driven
by technological advancements, an expanding healthcare infrastructure,
increasing awareness, and rising demand from the medical tourism sector. The
market is likely to witness further innovations in diagnostic techniques,
treatment protocols, and patient management systems, which will improve
outcomes for stomach cancer patients and provide more accessible and effective
care.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "UAE Stomach Cancer Treatment Market”
The UAE Stomach Cancer Treatment Market is segmented
into treatment type, disease indication, route of administration, drug class,
regional distribution, and company.
Based on route of administration, injectable
treatments was dominating over oral therapies. The preference for injectable
treatments can be attributed to several factors that cater to the need for more
effective and direct treatment options for stomach cancer. Injectables,
including chemotherapy drugs, targeted therapies, and immunotherapies, offer
faster absorption, more precise delivery, and better bioavailability compared
to oral treatments, making them highly effective in managing the aggressive
nature of stomach cancer.
Chemotherapy, which remains a cornerstone of stomach
cancer treatment, is most commonly administered through intravenous (IV)
injections or infusions, allowing for direct and concentrated delivery of drugs
to the bloodstream. This method ensures that the medication is quickly
circulated throughout the body, increasing its effectiveness in targeting
cancer cells. Chemotherapy treatments are often required in multiple cycles,
and injectable forms allow for better control over dosages, timing, and
frequency, making them more suitable for treating advanced-stage cancers. The
rise of targeted therapies and immunotherapies has also driven the preference
for injectable treatments in the UAE. These therapies are designed to target
specific molecules involved in cancer cell growth, providing a more targeted
and personalized approach to treatment. While oral targeted therapies exist,
injectables are still the dominant form due to their higher efficiency in
delivering the medication directly to cancer cells. Immunotherapies, which help
the immune system recognize and fight cancer, are typically administered via
injection to ensure faster action and effectiveness, particularly for cancers
like stomach cancer that can become resistant to traditional treatments.
Based on region, in the UAE Stomach Cancer Treatment
Market, Sharjah wasthe second most dominant region, following Abu Dhabi.
Sharjah has witnessed significant growth in healthcare infrastructure and
medical services over the past few years, establishing itself as a prominent
hub for medical treatments in the country. While Abu Dhabi, with its
well-established healthcare network and large number of specialized cancer
treatment centers, leads the market, Sharjah’s increasing healthcare
developments are contributing to its growing share in the stomach cancer
treatment market.
One of the primary factors driving Sharjah’s rise in
the UAE Stomach Cancer Treatment Market is the increasing accessibility to
high-quality healthcare services. The region is home to numerous hospitals and
specialized cancer care centers, which are expanding their capabilities to
cater to the rising demand for cancer treatment, including advanced therapies
for stomach cancer. Institutions like Al Qassimi Hospital and the University
Hospital Sharjah have established themselves as key players in providing cancer
care and have integrated state-of-the-art medical technologies for diagnosing
and treating stomach cancer.
Major companies operating in UAE Stomach Cancer
Treatment Market are:
- Thermo Fisher Scientific Middle East
- Bristol Myers Squibb, Middle East
& Africa FZ-LLC
- Illumina Dubai Middle East FZE
- Roche Diagnostics Middle East FZCO
- Gulf Bio Analytical LLC
- Abbott Laboratories S.A.
- Hitachi Ltd.
- Gulf International Cancer Center
- Pfizer Gulf FZ LLC
- AstraGene LLC
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The future of the UAE Stomach Cancer Treatment Market
looks promising, driven by continuous advancements in medical technology,
increasing healthcare awareness, and growing demand for specialized cancer
treatments. The UAE's healthcare infrastructure is expected to expand further,
with a focus on integrating advanced diagnostic tools, minimally invasive
treatment options, and personalized therapies. As the population becomes more
proactive about health and early diagnosis, the market will see a rise in early-stage
stomach cancer detection and treatment. In addition, the ongoing investment in
medical research and clinical trials will enable the development of more
effective therapies, including immunotherapies and targeted treatments,
specifically tailored to combat stomach cancer. The government's focus on
improving healthcare accessibility, particularly through medical tourism, will
continue to attract patients from across the region seeking state-of-the-art
treatments in the UAE.,” said Mr. Karan Chechi, Research Director, TechSci
Research, a research-based management consulting firm.
“UAE Stomach Cancer
Treatment Market By Treatment Type (Standard Chemotherapy, Targeted
Therapy, and Immunotherapy), By Disease Indication (Gastric
cancer/Gastroesophageal Junction cancer, Gastrointestinal Stromal Tumours), By
Route Of Administration (Oral and Injectable), By Drug Class (PD-1/PD-L1
Inhibitors, HER2 Antagonists, VEGFR Antagonists, and Others), By Region, Competition, Forecast and Opportunities, 2020-2030F”, has evaluated the future growth potential of UAE Stomach
Cancer Treatment Market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in UAE Stomach
Cancer Treatment Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com